Posted on April 14, 20224/14/22
Impact of Patient Reported Outcome Measures on HTA Decisions for Rare Diseases
Posted on April 7, 20224/7/22
Reigniting Revenue for Established Brands
Posted on April 1, 20224/1/22
What You Need to Know as the European Union Embarks on Joint Health Technology Assessment (HTA)
Posted on February 24, 20222/24/22
THINK BEYOND THE THERAPY: Demystifying the Complexities of Cell and Gene Therapy Commercialization
Posted on February 24, 20222/24/22
Importance of Impactful Medical Information Content
Posted on January 26, 20221/26/22
Reversing the Complexity of Oncology Commercialization: How to solve for launch challenges in a chaotic ecosystem
Posted on December 22, 202112/22/21
Why Launching in Europe Is Unlike Launching Anywhere Else
Posted on December 21, 202112/21/21
Launch Sequencing and Market Prioritization in an Evolving Global Market
Posted on December 16, 202112/16/21
Rx-to-OTC Switch Tips: Identifying the Right Timing, Conditions, and Approach for Rx-to-OTC Conversion
Posted on December 6, 202112/6/21